Pfizer Establishes Collaboration With REGENXBIO to Develop Gene Therapies
News
Pfizer and REGENXBIO have established a new collaboration to develop gene therapies specifically designed to treat people with Friedreich’s ataxia. Under the terms of the agreement, Pfizer will be able ... Read more